Compare SXI & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXI | TWST |
|---|---|---|
| Founded | 1955 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.0B |
| IPO Year | 1994 | 2018 |
| Metric | SXI | TWST |
|---|---|---|
| Price | $263.38 | $49.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $281.33 | $48.75 |
| AVG Volume (30 Days) | 128.8K | ★ 1.4M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.53% | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ 1.42 | N/A |
| Revenue | ★ $604,535,000.00 | $376,572,000.00 |
| Revenue This Year | $15.98 | $18.89 |
| Revenue Next Year | $8.09 | $15.28 |
| P/E Ratio | $183.60 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $128.85 | $23.30 |
| 52 Week High | $270.87 | $57.88 |
| Indicator | SXI | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 59.12 | 56.28 |
| Support Level | $216.40 | $25.67 |
| Resistance Level | $266.94 | $57.88 |
| Average True Range (ATR) | 11.02 | 3.13 |
| MACD | 0.37 | -0.72 |
| Stochastic Oscillator | 78.62 | 42.43 |
Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.